Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlo Alviggi

Showing results (1-10 of 161) with videos related to

Pageof 17
Sort By:
Fertility and Sterility|April 3, 2022
Mild/moderate versus full stimulationCarlo Alviggi, Alessandro Conforti
Reproductive Biology and Endocrinology : RB&E|February 8, 2012
Hormonal, functional and genetic biomarkers in controlled ovarian stimulation: tools for matching patients and protocolsCarlo Alviggi, Peter Humaidan, Diego Ezcurra
Drugs|July 17, 2008
Lutropin alfa: a viewpoint by Giuseppe De Placido, Roberto Clarizia and Carlo AlviggiGiuseppe De Placido, Roberto Clarizia, Carlo Alviggi
Fertility and Sterility|April 20, 2025
Strengthening systematic review methods: reflections on Grading of Recommendations Assessment, Development and Evaluation, risk of bias, and clinical relevanceAlessandro Conforti, Sandro C Esteves, Carlo Alviggi
Fertility and Sterility|March 11, 2020
Ovarian reserve tests: Are they only a quantitative measure?Carlo Alviggi, Sandro C Esteves, Alessandro Conforti
Journal of Molecular Medicine (Berlin, Germany)|October 14, 2003
Unraveling the multiple roles of leptin in inflammation and autoimmunityAntonio La Cava, Carlo Alviggi, Giuseppe Matarese
Life (Basel, Switzerland)|October 28, 2023
Exploring the Impact of Controlled Ovarian Stimulation and Non-Invasive Oocyte Assessment in ART TreatmentsRomualdo Sciorio, Federica Cariati, Steven Fleming, et al.
Frontiers in Endocrinology|April 10, 2018
Response: Commentary: Efficacy of Follicle-Stimulating Hormone (FSH) Alone, FSH + Luteinizing Hormone, Human Menopausal Gonadotropin or FSH + Human Chorionic Gonadotropin on Assisted Reproductive Technology Outcomes in the "Personalized" Medicine Era: A Meta-analysisDaniele Santi, Livio Casarini, Carlo Alviggi, et al.
Frontiers in Endocrinology|June 17, 2017
Efficacy of Follicle-Stimulating Hormone (FSH) Alone, FSH + Luteinizing Hormone, Human Menopausal Gonadotropin or FSH + Human Chorionic Gonadotropin on Assisted Reproductive Technology Outcomes in the "Personalized" Medicine Era: A Meta-analysisDaniele Santi, Livio Casarini, Carlo Alviggi, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|June 16, 2020
A practical approach for the management of obstetric and infertile women during the phase two of the novel coronavirus disease 2019 (COVID -19) pandemicIlma Floriana Carbone, Alessandro Conforti, Antonio Farina, et al.
Pageof 17

Showing results (1-10 of 161) with videos related to

Sort By:
Pageof 17
Fertility and Sterility|April 3, 2022
Mild/moderate versus full stimulationCarlo Alviggi, Alessandro Conforti
Reproductive Biology and Endocrinology : RB&E|February 8, 2012
Hormonal, functional and genetic biomarkers in controlled ovarian stimulation: tools for matching patients and protocolsCarlo Alviggi, Peter Humaidan, Diego Ezcurra
Drugs|July 17, 2008
Lutropin alfa: a viewpoint by Giuseppe De Placido, Roberto Clarizia and Carlo AlviggiGiuseppe De Placido, Roberto Clarizia, Carlo Alviggi
Fertility and Sterility|April 20, 2025
Strengthening systematic review methods: reflections on Grading of Recommendations Assessment, Development and Evaluation, risk of bias, and clinical relevanceAlessandro Conforti, Sandro C Esteves, Carlo Alviggi
Fertility and Sterility|March 11, 2020
Ovarian reserve tests: Are they only a quantitative measure?Carlo Alviggi, Sandro C Esteves, Alessandro Conforti
Journal of Molecular Medicine (Berlin, Germany)|October 14, 2003
Unraveling the multiple roles of leptin in inflammation and autoimmunityAntonio La Cava, Carlo Alviggi, Giuseppe Matarese
Life (Basel, Switzerland)|October 28, 2023
Exploring the Impact of Controlled Ovarian Stimulation and Non-Invasive Oocyte Assessment in ART TreatmentsRomualdo Sciorio, Federica Cariati, Steven Fleming, et al.
Frontiers in Endocrinology|April 10, 2018
Response: Commentary: Efficacy of Follicle-Stimulating Hormone (FSH) Alone, FSH + Luteinizing Hormone, Human Menopausal Gonadotropin or FSH + Human Chorionic Gonadotropin on Assisted Reproductive Technology Outcomes in the "Personalized" Medicine Era: A Meta-analysisDaniele Santi, Livio Casarini, Carlo Alviggi, et al.
Frontiers in Endocrinology|June 17, 2017
Efficacy of Follicle-Stimulating Hormone (FSH) Alone, FSH + Luteinizing Hormone, Human Menopausal Gonadotropin or FSH + Human Chorionic Gonadotropin on Assisted Reproductive Technology Outcomes in the "Personalized" Medicine Era: A Meta-analysisDaniele Santi, Livio Casarini, Carlo Alviggi, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|June 16, 2020
A practical approach for the management of obstetric and infertile women during the phase two of the novel coronavirus disease 2019 (COVID -19) pandemicIlma Floriana Carbone, Alessandro Conforti, Antonio Farina, et al.
Pageof 17